Current Technologies for Sub-Micrometer and Micrometer Particle Analysis for Biologics

Introduction Analyzing and controlling the particle content in biopharmaceutical drug products is a challenge scientists must face throughout a product’s life cycle starting at early drug research, during drug product development, manufacturing and storage. Particles can hereby originate from the ...

To read the full article and other articles in this issue, please register for an account or log in.

We will not sell your information to a third party. See our Privacy Policy



Related Products